UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Half of cosmetics claiming anti-fine dust effect falsely advertised
Half of the cosmetic products that claimed to block the skin from fine dust...
by Lee Hye-seon
|
2018-11-14 11:54
라인
Orders for ingredients of antitussives, expectorants surge amid fine dust
Orders for active pharmaceutical ingredients (API) for cough suppressants a...
by Nam Doo-hyun
|
2018-11-14 11:48
라인
Boehringer, Lilly release new research for Jardiance
Boehringer Ingelheim and Eli Lilly have presented its result on EMPRISE rea...
by Lee Han-soo
|
2018-11-13 17:17
라인
AstraZeneca confirms decrease of heart failure in diabetics using Forxiga
AstraZeneca has presented a new study on Forxiga, an SGLT-2 inhibitor for t...
by Lee Han-soo
|
2018-11-13 15:56
라인
Chong Kun Dang challenges to beat Pfizer’s rheumatoid arthritis drug
While domestic pharmaceutical firms voluntarily withdrew patent suits again...
by So Jae-hyeon
|
2018-11-13 15:03
라인
Which drugmakers will mark over ₩1 trillion sales this year?
Pharmaceutical industry officials are paying keen attention which companies...
by So Jae-hyeon
|
2018-11-13 13:08
라인
Huons Global surpasses ₩100 billion in sales for the first time in Q3
Huons Global said Tuesday the company and its subsidiaries recorded 100.3 b...
by Lee Han-soo
|
2018-11-13 13:07
라인
Ministry OKs P2 clinical trials for OliX’s anti-scar therapeutics
OliX Pharmaceuticals said Monday that it has received approval from the Min...
by Lee Han-soo
|
2018-11-13 10:31
라인
Korea Vaccine in tight spot due to tainted BCG, dosshouse fire
Korea Vaccine has emerged as the center of controversy, as it is involved i...
by So Jae-hyeon
|
2018-11-12 17:13
라인
Hugel wins patent for liquid-form botox
Hugel said Monday that it has registered a patent regarding a method to pre...
by Lee Han-soo
|
2018-11-12 14:31
라인
Hanmi applies for breakthrough therapy designation for lung cancer drug
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Thursday that it has ap...
by Lee Han-soo
|
2018-11-09 16:41
라인
Daewoong’s botulinum toxin wins indication for crow’s feet
Daewoong Pharmaceutical said it has expanded the indication of Nabota, the ...
by So Jae-hyeon
|
2018-11-09 15:27
라인
[Exclusive] Wholesaler allegedly smuggled obesity drug Saxenda into China
A Korean wholesaler has allegedly smuggled popular obesity drug Saxenda int...
by So Jae-hyeon
|
2018-11-09 14:59
라인
‘JAK inhibitors to change quality of life for people with polycythemia vera’
“Janus kinase (JAK) inhibitors, a type of medication that suppresses the ac...
by Park Gi-taek
|
2018-11-09 13:32
라인
Sanofi releases 2 clinical trial results for antidiabetic treatment
Sanofi Aventis Korea has unveiled two phase 3 clinical trial results for So...
by Lee Han-soo
|
2018-11-08 17:13
라인
Ildong Hyaltech to export HA filler to Brazil
Ildong Hyaltech, a subsidiary of Ildong Pharmaceutical, said Thursday that ...
by Lee Han-soo
|
2018-11-08 15:16
라인
Dong-A ST’s athlete’s foot treatment exceeds annual sales of ₩10 billion
Dong-A ST said Thursday that Jublia, a toenail fungal treatment, has surpas...
by Lee Han-soo
|
2018-11-08 15:16
라인
Well Marker Bio raises ₩28 billion for anticancer drug development
Anticancer treatment developer Well Marker Bio said it has completed the so...
by Lee Hye-seon
|
2018-11-08 15:10
라인
Hanmi rolls out new generic drug to beat Pfizer’s anti-nicotine therapy
After failing to outrival Pfizer in the anti-smoking treatment market with ...
by So Jae-hyeon
|
2018-11-07 16:07
라인
Ministry OKs P1 clinical trials for JW’s atopy treatment
JW Pharmaceutical said Wednesday that it has received approval from the Min...
by Lee Han-soo
|
2018-11-07 16:06
-
이전
61
62
63
64
65
66
67
68
69
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top